Alberto Álvarez-Larrán (Alberto Alvarez-Larrán, Alberto Alvarez-Larran)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

American journal of hematology

British journal of haematology

Annals of hematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Francisca Ferrer-Marín, Juan Carlos Carlos Hernández-Boluda, Alberto Álvarez-Larrán
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon. British journal of haematology (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Alberto Álvarez-Larrán
REVEAL puts leukocytes into risk stratification. Blood 143 (16) (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology (2024)
Alberto Álvarez-Larrán
REVEAL puts leukocytes into risk stratification. Blood 143 (16) (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Francisca Ferrer-Marín, Juan Carlos Carlos Hernández-Boluda, Alberto Álvarez-Larrán
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon. British journal of haematology 204 (5) (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Giovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline, Lambert Busque, Ester Pungolino, Elisabetta Abruzzese, Maria Cristina Miggiano, Chiara Elena, Alberto Álvarez-Larrán, Ana Triguero, Alessandra Iurlo, Cristina Bucelli, Marco Cerrano, Isabella Capodanno, Francesca Lunghi, Philipp le Coutre, Sara Galimberti, Giovanni Caocci, Margherita Maffioli, Fabio Stagno, Susanne Saussele, Rocco Giovanni Piazza, Brian J Druker, Carmen Fava, Veronica Guglielmana, Federica Colombo, Laura Antolini, Carlo B Gambacorti-Passerini
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study. American journal of hematology (2023)
Carlos Jiménez-Vicente, Marta Garrote, Mónica López-Guerra, Eva Villamón, Francesca Guijarro, Amanda Isabel Perez-Valencia, Alexandra Martinez-Roca, Olga Balaguer, Alberto Álvarez-Larrán, Juan Carlos Hernández-Boluda, Montserrat Rovira, Dolors Colomer, Marina Diaz-Beyá, Maria Rozman, Jordi Esteve
A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition. Leukemia & lymphoma 65 (3) (2023)
Carlos Jiménez-Vicente, Marta Garrote, Mónica López-Guerra, Eva Villamón, Francesca Guijarro, Amanda Isabel Perez-Valencia, Alexandra Martinez-Roca, Olga Balaguer, Alberto Álvarez-Larrán, Juan Carlos Hernández-Boluda, Montserrat Rovira, Dolors Colomer, Marina Diaz-Beyá, Maria Rozman, Jordi Esteve
A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition. Leukemia & lymphoma 65 (3) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Carlos Jiménez-Vicente, Marta Garrote, Mónica López-Guerra, Eva Villamón, Francesca Guijarro, Amanda Isabel Perez-Valencia, Alexandra Martinez-Roca, Olga Balaguer, Alberto Álvarez-Larrán, Juan Carlos Hernández-Boluda, Montserrat Rovira, Dolors Colomer, Marina Diaz-Beyá, Maria Rozman, Jordi Esteve
A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition. Leukemia & lymphoma (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Juan Carlos Carlos Hernández-Boluda, Irene Pastor-Galán, Eduardo Arellano-Rodrigo, José-María Raya, Manuel Pérez-Encinas, Rosa María Ayala, Francisca Ferrer-Marín, Patricia Velez, Elvira Mora, María-Laura Fox, Jesús-María Hernández-Rivas, Blanca Xicoy Cirici, María-Isabel Mata-Vázquez, María García-Fortes, Raúl Pérez-López, Anna Angona, Beatriz Cuevas, Alicia Senín, María-José Ramírez, Angel Ramírez-Payer, María-Teresa Gómez-Casares, Clara Martínez-Valverde, Elena Magro, Juan-Luis Steegmann, María-Antonia Durán, Carmen García-Hernández, Mercedes Gasior, Sonia González de Villambrosia, Alberto Álvarez-Larrán, Arturo Pereira, null null
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis. British journal of haematology 199 (4) (2022)
Alberto Álvarez-Larrán, Marta Garrote, Francisca Ferrer-Marín, Manuel Pérez-Encinas, M Isabel Mata-Vazquez, Beatriz Bellosillo, Eduardo Arellano-Rodrigo, Montse Gómez, Regina García, J Valentín García-Gutiérrez, Mercedes Gasior, Beatriz Cuevas, Anna Angona, María Teresa Gómez-Casares, Clara M Martínez, Elena Magro, Rosa Ayala, Rafael Del Orbe-Barreto, Raúl Pérez-López, Maria Laura Fox, José-María Raya, Lucía Guerrero, Carmen García-Hernández, Gonzalo Caballero, Ilda Murillo, Blanca Xicoy, M José Ramírez, Gonzalo Carreño-Tarragona, Juan Carlos Hernández-Boluda, Arturo Pereira, null null
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Cancer 128 (13) (2022)
Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, Alessandra Iurlo, Marta Anna Sobas, Elena Maria Elli, Elisa Rumi, Valerio De Stefano, Francesca Lunghi, Monia Marchetti, Rosa Daffini, Mercedes Gasior Kabat, Beatriz Cuevas, Maria Laura Fox, Marcio Miguel Andrade-Campos, Francesca Palandri, Paola Guglielmelli, Giulia Benevolo, Claire Harrison, Maria-Angeles Foncillas, Massimiliano Bonifacio, Alberto Álvarez-Larrán, Jean-Jacques Kiladjian, Estefanía Bolaños Calderón, Andrea Patriarca, Keina Susana Quiroz Cervantes, Martin Griesshammer, J Valentín García-Gutiérrez, Alberto Marin Sanchez, Elena Magro Mazo, Giuseppe Carli, Juan Carlos Carlos Hernández-Boluda, Santiago Osorio, Gonzalo Carreno-Tarragona, Miguel Sagues Serrano, Rajko Kusec, Begona Navas Elorza, Anna Angona, Blanca Xicoy Cirici, Emma Lopez Abadia, Steffen Koschmieder, Daniele Cattaneo, Cristina Bucelli, Edyta Cichocka, Anna Kulikowska de Nałęcz, Fabrizio Cavalca, Oscar Borsani, Silvia Betti, Marta Bellini, Natalia Curto-Garcia, Alessandro Rambaldi, Alessandro Maria Vannucchi
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19. American journal of hematology 97 (12) (2022)
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, Raajit K Rampal, Srdan Verstovsek, Moshe Talpaz, Jean-Jacques Kiladjian, Ruben A Mesa, Andrew T Kuykendall, Alessandro Maria Maria Vannucchi, Francesca Palandri, Sebastian Grosicki, Timothy Devos, Eric Jourdan, Marielle J Wondergem, Haifa Kathrin Al-Ali, Veronika Buxhofer-Ausch, Alberto Álvarez-Larrán, Andrea Patriarca, Marina Kremyanskaya, Adam J Mead, Sanjay Akhani, Yuri Sheikine, Gozde Colak, John O Mascarenhas
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. Future oncology (London, England) 18 (27) (2022)
Juan Carlos Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, Jan J Cornelissen, Jürgen Finke, Dietrich Beelen, Moniek de Witte, Keith Wilson, Uwe Platzbecker, Henrik Sengeloev, Didier Blaise, Hermann Einsele, Katja Sockel, William Krüger, Stig Lenhoff, Adriano Salaroli, Hans Martin, J Valentín García-Gutiérrez, Vicenzo Pavone, Alberto Álvarez-Larrán, José-María Raya, Nienke Zinger, Luuk Gras, Patrick Hayden, Tomasz Czerw, Donal P McLornan, Ibrahim Yakoub-Agha
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry. American journal of hematology 96 (10) (2021)
Alberto Álvarez-Larrán, Anna Angona, Marcio Andrade-Campos, M Soledad Noya, M Teresa Gómez-Casares, Beatriz Cuevas, Gonzalo Caballero, Carmen García-Hernández, Valentín García-Gutiérrez, Alicia Palomino, Francisca Ferrer-Marín, M Isabel Mata-Vázquez, Ana Moretó, Elena Magro, Ilda Murillo, Juan Manuel Alonso-Domínguez, José María Guerra, Lucía Guerrero, José María Raya, Manuel Pérez-Encinas, Gonzalo Carreño-Tarragona, Laura Fox, Irene Pastor-Galán, Beatriz Bellosillo, Juan Carlos Carlos Hernández-Boluda, null null
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia. British journal of haematology 192 (6) (2020)
Alberto Álvarez-Larrán, Arturo Pereira, Marta Magaz, Juan Carlos Hernández-Boluda, Marta Garrote, Beatriz Cuevas, Francisca Ferrer-Marín, M Teresa Gómez-Casares, Valentín García-Gutiérrez, M Isabel Mata-Vázquez, Fanny Turon, Virginia Hernandez-Gea, Eduardo Arellano-Rodrigo, Francisco Cervantes, Juan Carlos García-Pagán, null null
Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis. Annals of hematology 99 (4) (2020)
Alberto Álvarez-Larrán, Mónica López-Guerra, María Rozman, Juan-Gonzalo Correa, Juan Carlos Hernández-Boluda, Mar Tormo, Daniel Martínez, Iván Martín, Dolors Colomer, Jordi Esteve, Francisco Cervantes
Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis. Annals of hematology 98 (10) (2019)
Alvaro March-Rodriguez, Beatriz Bellosillo, Alberto Álvarez-Larrán, Carles Besses, Ramon Maria Pujol, Agustín Toll
Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib. Annals of dermatology 31 (2) (2019)
Alberto Álvarez-Larrán
Atrial fibrillation and MPNs. Annals of hematology 97 (4) (2018)
Alberto Álvarez-Larrán, Daniel Martínez, Leonor Arenillas, Ariadna Rubio, Eduardo Arellano-Rodrigo, Juan Carlos Hernández Boluda, Natalia Papaleo, Gonzalo Caballero, Clara Martínez, Francisca Ferrer-Marín, María Isabel Mata, Manuel Pérez-Encinas, María Antonia Durán, José María Alonso, Gonzalo Carreño-Tarragona, Juan Manuel Alonso, Soledad Noya, Elena Magro, Raúl Pérez, Mónica López-Guerra, Irene Pastor-Galán, Francisco Cervantes, Carlos Besses, Luis Colomo, María Rozman
Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes. Journal of clinical pathology 71 (11) (2018)
Alicia Senín, Concepción Fernández-Rodríguez, Beatriz Bellosillo, Laura Camacho, Raquel Longarón, Anna Angona, Carles Besses, Alberto Álvarez-Larrán
Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up. Annals of hematology 97 (3) (2017)
Alberto Álvarez-Larrán, Alicia Senín, Concepción Fernández-Rodríguez, Arturo Pereira, Eduardo Arellano-Rodrigo, Montse Gómez, Francisca Ferrer-Marín, Joaquín Martínez-López, Laura Camacho, Dolors Colomer, Anna Angona, Blanca Navarro, Francisco Cervantes, Carlos Besses, Beatriz Bellosillo, Juan Carlos Carlos Hernández-Boluda
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia. British journal of haematology 178 (5) (2017)

Alberto Álvarez-Larrán.css-eqlu8i{font-size:small;padding-left:4px;} (Alberto Alvarez-Larrán, Alberto Alvarez-Larran)

Publication Activity (10 Years)

Top Topics

Top Venues

Alberto Álvarez-Larrán (Alberto Alvarez-Larrán, Alberto Alvarez-Larran)